Kairos Pharma KAPA
NYSE KAPA
$0.55 +0.01 (+1.05%)
As of: Oct 23, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Cash from Operations (2023 - 2025)

Updated

Kairos Pharma's Cash from Operations came in at -$3.44 million for FY2025, compared with -$3.96 million in FY2024.

Analysis

Kairos Pharma (KAPA) Cash from Operations (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Cash from Operations at -$3.96 million in FY2024 and $81,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 7.72 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.44 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.57 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 835.00 Mn
10 Kairos Pharma 10.50 Mn -1.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -805,000.00
Mar 31, 2025 -714,000.00
Dec 31, 2024 -1.80 Mn
Sep 30, 2024 -2.02 Mn
Jun 30, 2024 -168,000.00
Mar 31, 2024 36,000.00
Dec 31, 2023 66,000.00
API Access

Kairos Pharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=KAPA&period=max&api_key=YOUR_API_KEY